ENDP - Endo International plc
18.04 -0.02 (-0.11%)
After hours: 4:33PM EDT
| Previous Close | 17.53 |
| Open | 17.48 |
| Bid | 17.34 x 1000 |
| Ask | 18.05 x 800 |
| Day's Range | 17.42 - 18.12 |
| 52 Week Range | 5.27 - 18.50 |
| Volume | 2,839,290 |
| Avg. Volume | 4,590,881 |
| Market Cap | 4.044B |
| Beta (3Y Monthly) | 0.08 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.61 |
| Earnings Date | Nov 8, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 17.27 |
Markit•9 hours agoSee what the IHS Markit Score report has to say about Endo International PLC.
Endo International PLC NASDAQ/NGS:ENDP
- ACCESSWIRE•3 days ago
Today's Research Reports on Trending Tickers: Endo International and Amarin
NEW YORK, NY / ACCESSWIRE / October 19, 2018 / U.S. equities plunged on Thursday as worries over global growth weighed on the broader market and investors continued to digest the minutes from the Federal ...
- Zacks•10 days ago
Rigel (RIGL) Gets EMA Acceptance for Thrombocytopenia Drug
The EMA validates Rigel Pharmaceuticals' (RIGL) marketing application for thrombocytopenia drug, Tavalisse.
- PR Newswire•11 days ago
Endo Presents Data on the Perception and Measurement of Cellulite Severity at the American Society for Dermatologic Surgery (ASDS) Annual Meeting
DUBLIN, Oct. 11, 2018 /PRNewswire/ -- Endo International plc (ENDP) today announced that data regarding the evaluation and rating of cellulite severity will be presented at the Annual Meeting of the American Society for Dermatologic Surgery (ASDS) in Phoenix, AZ. The results indicate that the gender of a HCP does not appear to impact assessment of cellulite severity ratings.
Yahoo Finance•13 days agoOpioid antidote inventor: We're in the 'next phase of this opioid crisis'
"We are now in the next phase of this opioid crisis, where the majority of deaths arise from fentanyl.”
Markit•14 days agoSee what the IHS Markit Score report has to say about Endo International PLC.
Endo International PLC NASDAQ/NGS:ENDP
- Zacks•21 days ago
Endo Recalls 2 Lots of Robaxin Tablets Due to Labeling Error
Endo International (ENDP) recalls two lots of Robaxin 750mg Tablets due to wrong dosing information on the label.
- PR Newswire•24 days ago
Endo to Announce Third-Quarter 2018 Financial Results
DUBLIN , Sept. 28, 2018 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) will announce its third-quarter 2018 financial results on November 8, 2018 and members of its senior management team will host ...
- The Wall Street Journal•24 days ago
[$$] Endo Recalls Robaxin Tablets Due to Dosing Error
PLC (ENDP) on Friday said its Endo Pharmaceuticals Inc. unit is recalling two lots of the muscle relaxant Robaxin due to incorrect dosing information on the label that could lead to overdose. Endo said patients who follow the incorrect directions could experience significant drowsiness or dizziness that would put them at risk for falls or an overdose that could result in seizures, coma or death. An Endo spokeswoman said the recall, which affects about 2,856 bottles of tablets, was voluntary and precautionary, and that the company hasn’t received any reports of injuries or serious adverse reactions related to the issue.
- Zacks•24 days ago
Forget Mylan, Invest in These 3 Generic/Drug Stocks Instead
Given the recent spate of setbacks suffered by Mylan (MYL), we suggest investing in better-ranked generic/drug companies with favorable growth profile.
- Zacks•24 days ago
Has Endo International plc (ENDP) Outpaced Other Medical Stocks This Year?
Is (ENDP) Outperforming Other Medical Stocks This Year?
- ACCESSWIRE•24 days ago
Today's Research Reports on Trending Tickers: TherapeuticsMD and Endo International
NEW YORK, NY / ACCESSWIRE / September 28, 2018 / U.S. markets finished higher on Thursday as the jobless claims increase was smaller than expected and second quarter GDP rose 3.1%, marking the best growth ...
- PR Newswire•24 days ago
Endo Pharmaceuticals Issues Voluntary Nationwide Recall for Two Lots of Robaxin® 750mg Tablets 100 Count Bottle Packs Due to Incorrect Daily Dosing Information on Label
DUBLIN , Sept. 28, 2018 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that one of its operating companies, Endo Pharmaceuticals Inc., is voluntarily recalling two lots of Robaxin® ...
- GlobeNewswire•25 days ago
Recent Analysis Shows Golar LNG, Grupo Aeroportuario del Centro Norte S.A.B. de C.V, Oracle, Ross Stores, Mellanox Technologies, and Endo International plc Market Influences — Renewed Outlook, Key Drivers of Growth
NEW YORK, Sept. 27, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
- Reuters•28 days ago
Endo puts Vasostrict case against U.S. FDA on hold
Endo International Plc is halting its lawsuit against the U.S. Food And Drug Administration until the end of the year after the agency made new commitments on the regulation relating to the active ingredient in blood pressure medicine Vasostrict. Last month, the FDA proposed excluding three substances from a list of ingredients that could be used to manufacture compounded medications in bulk, including vasopressin, the active ingredient in Vasostrict. "We believe that a brief additional stay of our litigation is appropriate to allow FDA to complete its rulemaking process," Matthew Maletta, Endo's chief legal officer, said in a statement on Monday.
- PR Newswire•28 days ago
Endo Agrees to Additional Stay of FDA Litigation Following FDA's Commitment to Use Best Efforts to Finalize Vasopressin Clinical Need Determination By Year End
DUBLIN , Sept. 24, 2018 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that it has agreed to an additional stay of its litigation against the U.S. Food and Drug Administration (FDA) ...
Markit•last monthSee what the IHS Markit Score report has to say about Endo International PLC.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, growth of ETFs holding ENDP is favorable, with net inflows of $20.59 billion.
- Zacks•last month
Is Endo International (ENDP) a Great Stock for Value Investors?
Is Endo International (ENDP) a great pick from the value investor's perspective right now? Read on to know more.
Markit•last monthSee what the IHS Markit Score report has to say about Endo International PLC.
Endo International PLC NASDAQ/NGS:ENDP
- Zacks•last month
The Zacks Analyst Blog Highlights: Ingersoll-Rand, Endo International, Glanbia and Smurfit Kappa Group
The Zacks Analyst Blog Highlights: Ingersoll-Rand, Endo International, Glanbia and Smurfit Kappa Group
Markit•last monthSee what the IHS Markit Score report has to say about Endo International PLC.
Endo International PLC NASDAQ/NGS:ENDP
- Insider Monkey•last month
5 Problematic Stocks Francis Chou Dared To Buy
Francis Chou, a well-regarded Canadian value investor, the founder of Chou Associates Management, and Morningstar Fund Manager of the Decade in 2004, was once just an ordinary immigrant in Canada with $200 in his pocket. Even though he is Chinese, he was born and raised in India, and came to Canada looking for a job. For […]
- Zacks•last month
Irish Economy Rebounds in Q2: 4 Great Picks
Ireland's growth in the past few years not only shows its resilience to the economic downturn in the EU but also makes it one of the most business-friendly destinations of the region.
Markit•last monthSee what the IHS Markit Score report has to say about Endo International PLC.
Endo International PLC NASDAQ/NGS:ENDP
